SEC Comment Letter 0000000000-25-003440 to Longeveron Inc. (LGVN)
Longeveron Inc.
Date: March 31, 2025 · CIK: 0001721484 · Accession: 0000000000-25-003440
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-286217
Letter
Re: Longeveron Inc. Registration Statement on Form S-3 Filed March 28, 2025 File No. 333-286217 Dear Wa el Hashad:
March 31, 2025
Wa el Hashad Chief Executive Officer Longeveron Inc. 1951 NW 7th Avenue, Suite 520 Miami, FL 33136
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jason Drory at 202-551-8342 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Jennifer Minter
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> March 31, 2025 Wa el Hashad Chief Executive Officer Longeveron Inc. 1951 NW 7th Avenue, Suite 520 Miami, FL 33136 Re: Longeveron Inc. Registration Statement on Form S-3 Filed March 28, 2025 File No. 333-286217 Dear Wa el Hashad: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jason Drory at 202-551-8342 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Jennifer Minter </TEXT> </DOCUMENT>